首页> 外文会议>International AIDS Conference >Efficacy and Tolerance of TRIZIVIR in a Cohort of Naive Advanced HIV-1 Infected Adults
【24h】

Efficacy and Tolerance of TRIZIVIR in a Cohort of Naive Advanced HIV-1 Infected Adults

机译:Trizivir在幼稚高级HIV-1感染成人队列中的疗效和耐受性

获取原文

摘要

The clinical benefits of a triple antiretroviral combinations with one nucleoside analog (DNA chain terminator), one protease inhibitor and either a second nucleoside analog ("NUK") or a non-nucleoside reverse transcriptase inhibitor (NNRTI) have been widely demonstrated in several randomised and controlled clinical trials.
机译:三种抗逆转录病毒组合与一种核苷类似物(DNA链终止剂),一种蛋白酶抑制剂和第二核苷类似物(“NUK”)或非核苷逆转录酶抑制剂(NNRTI)的临床益处已被广泛显示在几种随机化中和受控临床试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号